This post was also written by Steven D. Tibbets. A recent U.S. Court of Federal Claims bid protest decision illustrates how one agency’s apparent attempt to award a sole-source contract without making the findings to justify the award was unlawful, though, ultimately, the protest challenging award was not successful. The Court’s decision in Mobile Medical … Continue Reading
With more than 50 years of combined experience in Federal Supply Schedule (“FSS”) contracting, we have negotiated, administered, reviewed, investigated, litigated, and testified as experts about FSS contracts. Today’s FSS contracts can last up to 20 years. It’s difficult enough to look back over the prior 10 years of a contract life and try to … Continue Reading
On October 15, 2010, the Department of Defense (“DoD”) issued a final rule implementing Section 703 of the National Defense Authorization Act (“NDAA”). In this rule DoD takes the position that the NDAA requires pharmaceutical manufacturers to provide discounted drug prices based on the Veterans Health Care Act’s (“VHCA’s”) Federal Ceiling Price (“FCP”), for covered drugs … Continue Reading
